person · Reporting owner
CONCANNON CHRISTOPHER R
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cboe Global Markets, Inc.CBOE · Entity 3134 | President and COO | January 13, 2019 | January 15, 2019 |
| MARKETAXESS HOLDINGS INCMKTX · Entity 3821 | Director · Chief Executive Officer | April 03, 2026 | April 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cboe Global Markets, Inc.
Report date January 13, 2019 · Filed January 15, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 128,761 |
Reported balance
After 2019-01-13 transaction · row 1
1 source rowRow 1 · 2019-01-13 · Tax withholding · Disposed 802 · Balance 128,761 |
MARKETAXESS HOLDINGS INC
Report date April 03, 2026 · Filed April 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.003 per shareSEC Table I · non-derivative | Direct | 53,600 |
Reported balance
After 2026-04-03 transaction · row 1
1 source rowRow 1 · 2026-04-03 · Tax withholding · Disposed 349 · Balance 53,600 F1: Represents the surrender of shares to the Company to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units previously granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the surrender of shares to the Company to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units previously granted to the Reporting Person.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Bats Global Markets, Inc.
Report date February 28, 2017 · Filed March 02, 2017
Section 16 reporting ended · disclosed 2017-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-02-28 transaction · row 1
1 source rowRow 1 · 2017-02-28 · Disposition to issuer · Disposed 400,061 · Balance 0 F1: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger by and among the Issuer, CBOE Holdings, Inc. ("CBOE"), CBOE Corporation and CBOE V, LLC, dated as of September 25, 2016 (the "Merger Agreement"), each outstanding share of common stock of the Issuer ("Common Stock") was canceled and converted into the right to receive (i) 0.3201 of a share of common stock of CBOE, par value $0.01 per share ("CBOE Common Stock") and $10.00 in cash, (ii) an amount of cash, without interest, equal to the sum of (a) $10 and (b) the product obtained by multiplying 0.3201 by the volume-weighted average price of shares of CBOE Common Stock for the period of the ten consecutive trading days ending on the second full trading day prior to the Effective Time (the "Closing VWAP"), or (iii) a number of shares of CBOE Common Stock equal to the sum of (a)0.3201 and (b) the quotient obtained by dividing $10 by the Closing VWAP (the "Exchange Ratio"). F2: Includes: 79,856 shares of restricted Common Stock that are scheduled to vest 12/1/2018; 125,445 shares of restricted Common Stock that are scheduled to vest 12/1/2019; 70,740 shares of restricted Common Stock that are scheduled to vest 12/15/2019; 14,979 shares of restricted Common Stock that are scheduled to vest 1/13/2020. F3: Pursuant to the Merger Agreement, at the Effective Time, each outstanding award of restricted Common Stock held by the Reporting Person will be cancelled and converted into an award of restricted shares of CBOE Common Stock, subject to the same terms and conditions that applied to the applicable restricted Common Stock award immediately prior to the Effective Time (but taking into account any changes, including any acceleration of vesting of such shares of restricted Common Stock, occurring by reason provided for in the Merger Agreement). The number of shares of CBOE Common Stock subject to each such award shall be equal to the number of shares of Common Stock subject to the corresponding restricted Common Stock award multiplied by the Exchange Ratio. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.52 · Expires 2024-11-30 | Direct | 0 |
Reported balance
After 2017-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-02-28 · Disposition to issuer · Acquired 638,855 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each outstanding unexercised option to purchase Common Stock, whether vested or unvested ("Bats Stock Options"), will be converted into an option to purchase CBOE Common Stock, with the same terms and conditions (including vesting schedule) as were applicable to such Bats Stock Option (taking into account any acceleration of vesting due to the transactions contemplated by the Merger Agreement). The number of shares of CBOE Common Stock subject to each converted option will be equal to the number of shares of Common Stock subject to the corresponding Bats Stock Option immediately prior to the Effective Time multiplied by the Exchange Ratio (subject to certain adjustments and rounding), and the exercise price of such option to purchase CBOE Common Stock will be equal to the per share exercise price under the corresponding Bats Stock Option divided by the Exchange Ratio (subject to certain adjustments and rounding). F5: The stock options were granted on 12/1/2014 and vest 25% annually. 137,331 of these options will immediately vest at the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger by and among the Issuer, CBOE Holdings, Inc. ("CBOE"), CBOE Corporation and CBOE V, LLC, dated as of September 25, 2016 (the "Merger Agreement"), each outstanding share of common stock of the Issuer ("Common Stock") was canceled and converted into the right to receive (i) 0.3201 of a share of common stock of CBOE, par value $0.01 per share ("CBOE Common Stock") and $10.00 in cash, (ii) an amount of cash, without interest, equal to the sum of (a) $10 and (b) the product obtained by multiplying 0.3201 by the volume-weighted average price of shares of CBOE Common Stock for the period of the ten consecutive trading days ending on the second full trading day prior to the Effective Time (the "Closing VWAP"), or (iii) a number of shares of CBOE Common Stock equal to the sum of (a)0.3201 and (b) the quotient obtained by dividing $10 by the Closing VWAP (the "Exchange Ratio").
F2: Includes: 79,856 shares of restricted Common Stock that are scheduled to vest 12/1/2018; 125,445 shares of restricted Common Stock that are scheduled to vest 12/1/2019; 70,740 shares of restricted Common Stock that are scheduled to vest 12/15/2019; 14,979 shares of restricted Common Stock that are scheduled to vest 1/13/2020.
F3: Pursuant to the Merger Agreement, at the Effective Time, each outstanding award of restricted Common Stock held by the Reporting Person will be cancelled and converted into an award of restricted shares of CBOE Common Stock, subject to the same terms and conditions that applied to the applicable restricted Common Stock award immediately prior to the Effective Time (but taking into account any changes, including any acceleration of vesting of such shares of restricted Common Stock, occurring by reason provided for in the Merger Agreement). The number of shares of CBOE Common Stock subject to each such award shall be equal to the number of shares of Common Stock subject to the corresponding restricted Common Stock award multiplied by the Exchange Ratio.
F4: Pursuant to the Merger Agreement, at the Effective Time, each outstanding unexercised option to purchase Common Stock, whether vested or unvested ("Bats Stock Options"), will be converted into an option to purchase CBOE Common Stock, with the same terms and conditions (including vesting schedule) as were applicable to such Bats Stock Option (taking into account any acceleration of vesting due to the transactions contemplated by the Merger Agreement). The number of shares of CBOE Common Stock subject to each converted option will be equal to the number of shares of Common Stock subject to the corresponding Bats Stock Option immediately prior to the Effective Time multiplied by the Exchange Ratio (subject to certain adjustments and rounding), and the exercise price of such option to purchase CBOE Common Stock will be equal to the per share exercise price under the corresponding Bats Stock Option divided by the Exchange Ratio (subject to certain adjustments and rounding).
F5: The stock options were granted on 12/1/2014 and vest 25% annually. 137,331 of these options will immediately vest at the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2019 Filed May 16, 2019 20:14 UTC | MARKETAXESS HOLDINGS INC MKTX · Entity 3821 | Exercise / conversionCommon Stock, par value $0.003 per share | 8,969 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-030348 · doc4.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share represented a contingent right to receive a share of the Company's common stock upon the Company's attainment of certain levels of average price per share of the common stock, calculated based on the closing price of the common stock over any twenty consecutive trading days during the period from January 22, 2019 to January 22, 2024. On May 14, 2019, the Company issued 8,969 shares of restricted stock pursuant to the achievement of such performance objectives. The restricted stock will vest on January 22, 2024. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:18 UTC | MARKETAXESS HOLDINGS INC MKTX · Entity 3821 | GrantPerformance Shares · Derivative | 9,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-19-000093 · edgar.xml · derivative · entry 6 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,945 Underlying: Common Stock · 9,945 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of the Company's common stock. 9,945 shares of the Company's common stock will be awarded subject to the Company's attainment of an average price per share of $294.71, calculated based on the closing price of the common stock over any twenty consecutive trading days during the period from January 22, 2019 to January 22, 2024. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of the Company's common stock. 9,945 shares of the Company's common stock will be awarded subject to the Company's attainment of an average price per share of $294.71, calculated based on the closing price of the common stock over any twenty consecutive trading days during the period from January 22, 2019 to January 22, 2024. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of the Company's common stock. 9,945 shares of the Company's common stock will be awarded subject to the Company's attainment of an average price per share of $294.71, calculated based on the closing price of the common stock over any twenty consecutive trading days during the period from January 22, 2019 to January 22, 2024. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:18 UTC | MARKETAXESS HOLDINGS INC MKTX · Entity 3821 | GrantPerformance Shares · Derivative | 8,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-19-000093 · edgar.xml · derivative · entry 5 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,969 Underlying: Common Stock · 8,969 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of the Company's common stock. 8,969 shares of the Company's common stock will be awarded subject to the Company's attainment of an average price per share of $272.88, calculated based on the closing price of the common stock over any twenty consecutive trading days during the period from January 22, 2019 to January 22, 2024. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of the Company's common stock. 8,969 shares of the Company's common stock will be awarded subject to the Company's attainment of an average price per share of $272.88, calculated based on the closing price of the common stock over any twenty consecutive trading days during the period from January 22, 2019 to January 22, 2024. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of the Company's common stock. 8,969 shares of the Company's common stock will be awarded subject to the Company's attainment of an average price per share of $272.88, calculated based on the closing price of the common stock over any twenty consecutive trading days during the period from January 22, 2019 to January 22, 2024. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:18 UTC | MARKETAXESS HOLDINGS INC MKTX · Entity 3821 | GrantEmployee Stock Option (right to buy · Derivative | 41,189 | $0.00 Strike: $294.71 | $0.00 |
DisclosureSEC source: 0001012975-19-000093 · edgar.xml · derivative · entry 4 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,189 Underlying: Common Stock · 41,189 shares Expires 2024-07-22 Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:18 UTC | MARKETAXESS HOLDINGS INC MKTX · Entity 3821 | GrantEmployee Stock Option (right to buy · Derivative | 35,679 | $0.00 Strike: $272.88 | $0.00 |
DisclosureSEC source: 0001012975-19-000093 · edgar.xml · derivative · entry 3 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,679 Underlying: Common Stock · 35,679 shares Expires 2024-07-22 Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:18 UTC | MARKETAXESS HOLDINGS INC MKTX · Entity 3821 | GrantCommon Stock, par value $0.003 per share | 4,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-19-000093 · edgar.xml · nonDerivative · entry 2 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,995 F2 · price: Represents a grant of restricted stock units pursuant to the Company's 2012 Incentive Plan. The restricted stock units will vest on January 22, 2022. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 23:18 UTC | MARKETAXESS HOLDINGS INC MKTX · Entity 3821 | GrantCommon Stock, par value $0.003 per share | 23,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-19-000093 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 F1 · price: Represents a grant of restricted stock units pursuant to the Company's 2012 Incentive Plan. The restricted stock units will vest in three installments of 34% on January 22, 2020, and 33% on each of January 22, 2021 and January 22, 2022. Read SEC document |
| January 13, 2019 Filed Jan 15, 2019 22:07 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 802 | $91.39 | $73,294.78 |
DisclosureSEC source: 0001179110-19-000727 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,761 Read SEC document |
| December 15, 2018 Filed Dec 19, 2018 01:06 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 5,141 | $100.89 | $518,675.49 |
DisclosureSEC source: 0001179110-18-014095 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,563 Read SEC document |
| December 01, 2018 Filed Dec 4, 2018 21:04 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 9,117 | $107.62 | $981,171.54 |
DisclosureSEC source: 0001179110-18-013396 · edgar.xml · nonDerivative · entry 2 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,704 Read SEC document |
| December 01, 2018 Filed Dec 4, 2018 21:04 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 8,705 | $107.62 | $936,832.10 |
DisclosureSEC source: 0001179110-18-013396 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,821 Read SEC document |
| May 30, 2018 Filed May 31, 2018 20:02 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | PurchaseCommon Stock | 10,000 | $99.44 | $994,400.00 |
DisclosureSEC source: 0001179110-18-007716 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,526 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $99.39 to $99.52. The reporting person undertakes to provide to Cboe Global Markets, Inc., any security holder of Cboe Global Markets, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:45 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Exercise / conversionRestricted Stock Units · Derivative | 4,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003360 · edgar.xml · derivative · entry 3 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,292 Underlying: Common Stock · 4,146 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock. F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments, which began on February 28, 2018. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:45 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 2,031 | $112.01 | $227,492.31 |
DisclosureSEC source: 0001179110-18-003360 · edgar.xml · nonDerivative · entry 2 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,526 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:45 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Exercise / conversionCommon Stock | 4,146 | $112.01 | $464,393.46 |
DisclosureSEC source: 0001179110-18-003360 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 23:28 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantRestricted Stock Units · Derivative | 9,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002524 · edgar.xml · derivative · entry 2 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,366 Underlying: Common Stock · 9,366 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on February 19, 2019. F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on February 19, 2019. Read SEC document |
| January 13, 2018 Filed Jan 16, 2018 23:20 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 854 | $131.51 | $112,309.54 |
DisclosureSEC source: 0001179110-18-000892 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,411 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 23:27 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 5,414 | $126.37 | $684,167.18 |
DisclosureSEC source: 0001179110-17-015665 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,265 Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:58 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 9,601 | $124.25 | $1,192,924.25 |
DisclosureSEC source: 0001179110-17-014960 · edgar.xml · nonDerivative · entry 2 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,679 Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:58 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | Tax withholdingCommon Stock | 8,184 | $124.25 | $1,016,862.00 |
DisclosureSEC source: 0001179110-17-014960 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,280 Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 02:11 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantStock Option · Derivative | 162,136 | $0.00 Strike: $28.13 | $0.00 |
DisclosureSEC source: 0001104659-17-013669 · a4.xml · derivative · entry 5 CONCANNON CHRISTOPHER R · CIK 0001251713 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,136 Underlying: Common Stock · 162,136 shares Expires 2024-11-30 F6 · security: Represents an option to purchase shares of Bats common stock that was converted to an option to purchase shares of CBOE Holdings common stock pursuant to the Merger Agreement. F7 · derivative.exercise_date: Includes 50% of which are currently exercisable, 25% of which will vest on December 1, 2017 and 25% of which will vest on December 1, 2018. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 02:11 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantStock Option · Derivative | 122,281 | $0.00 Strike: $28.13 | $0.00 |
DisclosureSEC source: 0001104659-17-013669 · a4.xml · derivative · entry 4 CONCANNON CHRISTOPHER R · CIK 0001251713 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,281 Underlying: Common Stock · 122,281 shares Expires 2024-11-30 F6 · security: Represents an option to purchase shares of Bats common stock that was converted to an option to purchase shares of CBOE Holdings common stock pursuant to the Merger Agreement. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 02:11 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantRestricted Stock Units · Derivative | 12,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-013669 · a4.xml · derivative · entry 3 CONCANNON CHRISTOPHER R · CIK 0001251713 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,438 Underlying: Common Stock · 12,438 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CBOE Holdings common stock F5 · derivative.exercise_date: The restricted stock units vest in three equal annual installments, beginning on February 28, 2018. F5 · derivative.expiration_date: The restricted stock units vest in three equal annual installments, beginning on February 28, 2018. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 02:11 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantRestricted Stock Units · Derivative | 24,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-013669 · a4.xml · derivative · entry 2 CONCANNON CHRISTOPHER R · CIK 0001251713 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,876 Underlying: Common Stock · 24,876 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CBOE Holdings common stock F4 · derivative.exercise_date: The restricted stock units vest on February 28, 2020. F4 · derivative.expiration_date: The restricted stock units vest on February 28, 2020. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 02:11 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 164,464 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-17-013669 · a4.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,464 F1 · shares: Received upon conversion of 400,061 shares of Bats Global Markets, Inc. ("Bats") common stock, including 291,020 Bats unvested restricted shares pursuant to the Agreement and Plan of Merger, dated as of September 25, 2016 (the "Merger Agreement"), by and among CBOE Holdings, Inc. ("CBOE Holdings"), CBOE Corporation, CBOE V, LLC and Bats. On the effective date of the merger, the closing price of CBOE Holdings' common stock was $78.05 per share, and the closing price of Bats' common stock was $35.13. F2 · shares: Includes 35,551 shares of unvested restricted stock, half of which vest on each of December 1, 2017 and December 1, 2018; 55,848 shares of unvested restricted stock, a third of which vest on each of December 1, 2017, December 1, 2018 and December 1, 2019; 31,493 shares of unvested restricted stock, which vest ratably over three years; and 6,668 shares of unvested restricted stock which vest ratably over three years. F1 · price: Received upon conversion of 400,061 shares of Bats Global Markets, Inc. ("Bats") common stock, including 291,020 Bats unvested restricted shares pursuant to the Agreement and Plan of Merger, dated as of September 25, 2016 (the "Merger Agreement"), by and among CBOE Holdings, Inc. ("CBOE Holdings"), CBOE Corporation, CBOE V, LLC and Bats. On the effective date of the merger, the closing price of CBOE Holdings' common stock was $78.05 per share, and the closing price of Bats' common stock was $35.13. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 15:17 UTC | Bats Global Markets, Inc. BATS · Entity 178237 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 638,855 | $0.00 Strike: $12.52 | $0.00 |
DisclosureSEC source: 0001179110-17-003554 · edgar.xml · derivative · entry 2 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 638,855 shares Expires 2024-11-30 F4 · shares: Pursuant to the Merger Agreement, at the Effective Time, each outstanding unexercised option to purchase Common Stock, whether vested or unvested ("Bats Stock Options"), will be converted into an option to purchase CBOE Common Stock, with the same terms and conditions (including vesting schedule) as were applicable to such Bats Stock Option (taking into account any acceleration of vesting due to the transactions contemplated by the Merger Agreement). The number of shares of CBOE Common Stock subject to each converted option will be equal to the number of shares of Common Stock subject to the corresponding Bats Stock Option immediately prior to the Effective Time multiplied by the Exchange Ratio (subject to certain adjustments and rounding), and the exercise price of such option to purchase CBOE Common Stock will be equal to the per share exercise price under the corresponding Bats Stock Option divided by the Exchange Ratio (subject to certain adjustments and rounding). F5 · shares: The stock options were granted on 12/1/2014 and vest 25% annually. 137,331 of these options will immediately vest at the Effective Time. F5 · derivative.exercise_date: The stock options were granted on 12/1/2014 and vest 25% annually. 137,331 of these options will immediately vest at the Effective Time. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 15:17 UTC | Bats Global Markets, Inc. BATS · Entity 178237 | Disposition to issuerCommon Stock | 400,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-003554 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger by and among the Issuer, CBOE Holdings, Inc. ("CBOE"), CBOE Corporation and CBOE V, LLC, dated as of September 25, 2016 (the "Merger Agreement"), each outstanding share of common stock of the Issuer ("Common Stock") was canceled and converted into the right to receive (i) 0.3201 of a share of common stock of CBOE, par value $0.01 per share ("CBOE Common Stock") and $10.00 in cash, (ii) an amount of cash, without interest, equal to the sum of (a) $10 and (b) the product obtained by multiplying 0.3201 by the volume-weighted average price of shares of CBOE Common Stock for the period of the ten consecutive trading days ending on the second full trading day prior to the Effective Time (the "Closing VWAP"), or (iii) a number of shares of CBOE Common Stock equal to the sum of (a)0.3201 and (b) the quotient obtained by dividing $10 by the Closing VWAP (the "Exchange Ratio"). F2 · shares: Includes: 79,856 shares of restricted Common Stock that are scheduled to vest 12/1/2018; 125,445 shares of restricted Common Stock that are scheduled to vest 12/1/2019; 70,740 shares of restricted Common Stock that are scheduled to vest 12/15/2019; 14,979 shares of restricted Common Stock that are scheduled to vest 1/13/2020. F1 · price: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger by and among the Issuer, CBOE Holdings, Inc. ("CBOE"), CBOE Corporation and CBOE V, LLC, dated as of September 25, 2016 (the "Merger Agreement"), each outstanding share of common stock of the Issuer ("Common Stock") was canceled and converted into the right to receive (i) 0.3201 of a share of common stock of CBOE, par value $0.01 per share ("CBOE Common Stock") and $10.00 in cash, (ii) an amount of cash, without interest, equal to the sum of (a) $10 and (b) the product obtained by multiplying 0.3201 by the volume-weighted average price of shares of CBOE Common Stock for the period of the ten consecutive trading days ending on the second full trading day prior to the Effective Time (the "Closing VWAP"), or (iii) a number of shares of CBOE Common Stock equal to the sum of (a)0.3201 and (b) the quotient obtained by dividing $10 by the Closing VWAP (the "Exchange Ratio"). F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding award of restricted Common Stock held by the Reporting Person will be cancelled and converted into an award of restricted shares of CBOE Common Stock, subject to the same terms and conditions that applied to the applicable restricted Common Stock award immediately prior to the Effective Time (but taking into account any changes, including any acceleration of vesting of such shares of restricted Common Stock, occurring by reason provided for in the Merger Agreement). The number of shares of CBOE Common Stock subject to each such award shall be equal to the number of shares of Common Stock subject to the corresponding restricted Common Stock award multiplied by the Exchange Ratio. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 22:10 UTC | Bats Global Markets, Inc. BATS · Entity 178237 | GrantCommon Stock | 14,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001001 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,061 F1 · shares: Includes 14,979 shares of unvested restricted stock that vest ratably over the next three years. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:58 UTC | Bats Global Markets, Inc. BATS · Entity 178237 | GrantCommon Stock | 70,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-033209 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,082 F1 · shares: Includes 70,740 shares of unvested restricted stock that vests ratably over three years. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 22:31 UTC | Bats Global Markets, Inc. BATS · Entity 178237 | Tax withholdingCommon Stock | 37,630 | $31.95 | $1,202,278.50 |
DisclosureSEC source: 0001179110-16-032406 · edgar.xml · nonDerivative · entry 1 CONCANNON CHRISTOPHER R · CIK 0001251713 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,342 F1 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Issuer's Third Amended and Restated 2012 Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.